Hizentra Immune Globulin Subcutaneous (Human) 20% Liquid

Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid, is a prescription medicine used to treat: Primary immune deficiency (PI) in patients 2 years and older or Chronic inflammatory demyelinating polyneuropathy (CIDP) in adults. We hope our YouTube channel serves as a resource for people impacted by PI or CIDP in the US, including those who are already on Hizentra or want to learn more.
 
The information on this channel does not substitute for any medical advice or diagnosis of any health condition. Such issues should be directed to a licensed healthcare professional.
 
This page is brought to you by CSL Behring and complies with our Privacy Policy and Terms of Use, as well as YouTube’s Terms of Use. Additional information on Hizentra and the rules applicable to this channel can be found in the links below. 
 
Hizentra is manufactured by CSL Behring AG and distributed by CSL Behring LLC. Hizentra® is a registered trademark of CSL Behring AG. ©2019 CSL Behring LLC. HIZ-0957-SEP19